Global Intellectual Property Center

Blog and Trade

Do stay innovative, Prabhuji

Do stay innovative, Prabhuji

This article was originally published in the Economic Times on October 24, 2017. This week will signal a milestone in setting the course for US-India trade relations. Tomorrow, US Trade Representative Robert Lighthizer will meet his Indian counterpart, commerce and industry minister Suresh Prabhu, in Washington for the 11th round of the US-India Trade Policy Forum (TPF). […]

The Role of Intellectual Property in NAFTA Modernization

The Role of Intellectual Property in NAFTA Modernization

This article was originally published on Above the Fold on September 18, 2017. North America is having a political moment. Parties are not just polarized, but at times seem worlds apart. How leaders in North America react to the current paradigm will shape the future of the region for years. The decisions we make on […]

Leveraging Licensing for the Global Good

Leveraging Licensing for the Global Good

Economic growth, job creation, access to technology: all buzzwords at the top of government agendas around the world. Countries are making conscious policy investments to achieve these socioeconomic benefits. According to a new report, Leveraging Licensing for Technology Diffusion, Innovation, and Economic Activity, positive, voluntary licensing policies are a crucial means to attract these socioeconomic […]

What You Should Know About IPEC Nominee Vishal Amin

What You Should Know About IPEC Nominee Vishal Amin

Intellectual property (IP) industries – 81 to be exact – have a much greater influence on our economy than most Americans probably realize. According to the latest Department of Commerce report, IP impacts more than 45 million jobs and accounts for almost 40 percent of U.S. GDP. These numbers represent the many Americans that criminals […]

Make Sure Americans Get the Real Deal on Meds

Make Sure Americans Get the Real Deal on Meds

When Americans purchase medication for themselves or a loved one, the last thing they should worry about is whether they are getting what they paid for. Or whether it might actually harm them. Yet the public has reason to be alarmed should new drug importation legislation backed by Senator Bernie Sanders make its way into […]